GLP-1 Therapy for Weight Loss and Cravings

Target appetite, cravings, and the brain’s reward pathways with a medically guided GLP-1 program designed for sustainable change

GLP-1 medications offer a science-backed approach to weight loss by addressing the underlying biology of appetite, metabolism, and cravings—not just willpower. Dr. Decker works with patients to create a personalized plan using medications such as semaglutide and tirzepatide, tailored to your goals, physiology, and lifestyle.

Clinical trials have shown average weight loss of approximately 15–21% of body weight with GLP-1 medications after approximately 70 weeks, depending on the medication and dose. Beyond weight loss, this approach focuses on reducing cravings and supporting meaningful, lasting behavioral change.

How GLP-1 Medications Work

GLP-1 medications are similar to a natural hormone in our body that helps regulate:

  • Blood sugar

  • Appetite and satiety

  • Gastric emptying

  • Cravings and related behaviors

Potential Health Benefits

Depending on the dose and individual response, patients may experience:

  • Significant, sustained weight loss

  • Reduced appetite and earlier fullness

  • Decreased “food noise” and intrusive thoughts about eating and other cravings

  • Improvements in metabolic health markers

Beyond Weight Loss: Cravings & Addiction

GLP-1 medications are increasingly being studied for their effects on the brain’s reward system. This may help reduce:

  • Food cravings

  • Alcohol cravings

  • Nicotine use

While research is ongoing, early clinical data and patient experience suggest these effects can be meaningful—especially when combined with structured medical support.

Is a GLP-1 Medication Right for Me

You may be a candidate if you:

  • Are struggling with weight despite lifestyle efforts

  • Experience strong cravings or difficulty with appetite control

  • Are interested in a medically guided, structured approach

Eligibility is determined through a clinical evaluation and rigorous intake process. If GLP-1 medications are not appropriate, we work with you to determine an alternate plan and approach to the changes you are seeking. Learn more about common contraindications at our GLP-1 FAQ blog.

What to Expect

Your program is designed to provide both structure and flexibility, including:

  • A personalized treatment plan

  • Medication selection and dosing guidance

  • Ongoing follow-up and clinical support

We also address:

  • Nutrition and eating patterns

  • Lifestyle and daily habits

  • Behavioral change and cravings

  • Underlying contributors such as sleep, stress, mental and gut health

A GLP-1 intake visit is 45 minutes and $175. Follow-up visits are 30 minutes and $125.

Follow-up visits are a key part of the program and are typically scheduled every 6–8 weeks to track progress and optimize your results.

During follow-up visits, we may:

  • Review laboratory results and metabolic markers

  • Discuss your response to the medication, including weight and appetite changes

  • Address any side effects and implement changes as needed to improve tolerability

  • Evaluate cravings, mental health, and behavioral progress

  • Support digestive health and manage any GI-related symptoms

  • Adjust dosing or treatment strategies as needed

Long-Term Approach

GLP-1 medications are most effective when used as part of a long-term strategy—not a quick fix. Because of this, we focus on:

  • Sustainable habits that last beyond medication

  • Creating meaningful behavioral changes

  • Gradual transition to maintenance

Work with Us

If you’re ready to take a structured, medically supported approach to weight loss and cravings, we’re here to help.

call now
call now

Frequently Asked Questions About GLP-1 Weight Loss & Cravings Treatment

  • Clinical trials have shown average weight loss of approximately 15–21% of body weight over approximately 70 months, depending on the medication and dose. Individual results vary, but many patients begin noticing changes in appetite and weight within the first few weeks.

  • Many patients notice reduced appetite and fewer food cravings within the first 1–2 weeks. Weight loss typically becomes more noticeable over the first 2–3 months as dosing is gradually increased. Reduced cravings for other substances such as alcohol or nicotine may be seen within the first 1–3 months.

  • The most common side effects are gastrointestinal and may include nausea, diarrhea, or constipation. These are usually mild and improve over time. Careful dosing and appropriate treatment with natural or pharmaceutical anti-nausea medications or laxatives can help minimize side effects and improve tolerability.

  • Follow-up visits are typically scheduled every 6–8 weeks. These visits are used to monitor your progress, review labs if needed, adjust dosing, and address any side effects or changes in cravings, mental health, or digestion.

  • GLP-1 medications are most effective when used as part of a longer-term strategy. Some patients continue at a maintenance dose, while others transition off gradually. The goal is to support sustainable habits and long-term behavioral change.

  • No. While weight loss may be a primary goal for many, patients often are also interested in reducing cravings and improving their relationship with food. Emerging research suggests GLP-1 medications may also impact alcohol and other cravings.

  • Eligibility is determined through a clinical evaluation that reviews your health history, goals, and any contraindications. If GLP-1 medications are not appropriate, alternative options will be discussed.

  • Yes. This program is offered via telehealth, allowing you to receive care from home with ongoing medical support and follow-up.

  • This is not a one-size-fits-all program. Care is personalized and includes medical guidance, follow-up visits, and support for nutrition, lifestyle, and underlying contributors such as sleep, mental health, stress, and gut health.